Portal de investigação
Embracing Uncertainties Over the Evidence of New Oral Antivirals for COVID-19: Challenges in Pharmacoepidemiologic Research
Data de publicação:
Data Ahead of Print:
Autores da FMUP
Participantes de fora da FMUP
- Silva, A.
- Morato, M.
Unidades de investigação
Abstract
[No abstract available]
Dados da publicação
- ISSN/ISSNe:
- 1552-4604, 0091-2700
- Tipo:
- Editorial Material
- Páginas:
- 521-525
- DOI:
- 10.1002/jcph.2195
- Link para outro recurso:
- www.scopus.com
Journal of Clinical Pharmacology Wiley-Blackwell
Citações Recebidas na Scopus: 1
Documentos
- Não há documentos
Filiações
Keywords
- Antiviral Agents; COVID-19; Humans; Pharmacoepidemiology; Research Design; 3C viral protease; cytochrome P450 3A; molnupiravir; monoclonal antibody; n4 hydroxycytidine; nirmatrelvir; nirmatrelvir plus ritonavir; placebo; ribonucleoside; ritonavir; SARS-CoV-2 vaccine; virus RNA; antivirus agent; adverse drug reaction; antigenic escape; antiviral therapy; authorization; bacterial pneumonia; blister; breast feeding; circulation; clinical practice; clinical research; clinical trial (topic); coronavirus disease 2019; cost effectiveness analysis; data base; diarrhea; disease course; disease severity; dizziness; drug approval; drug efficacy; drug overdose; drug safety; drug use; dysgeusia; emergency use authorization; evidence based practice; Food and Drug Administration; good clinical practice; headache; health service; hospitalization; human; immunization; kidney dysfunction; kidney function; methodology; moderate renal impairment; multicenter study (topic); nausea; Note; pandemic; pharmaco
Proyectos asociados
Post-marketing Surveillance Study of the Effectiveness and Safety of New Oral Antivirals for Outpatients With Mild-moderate COVID-19 (ESOA-19) - NCT05894603
Investigador Principal: Renato Ivo Ferreira da Silva
Estudo Observacional Académico (ESOA-19) . 2022
Impact of EU label changes and regulatory communication on SARS-CoV-2 adenovirus vector vaccines in context of thrombosis with thrombocytopenia syndrome (TTS): risk awareness and adherence.
Investigador Principal: Fernanda Inês de Carvalho Pereira Ribeiro
Estudo Observacional Académco (RiskAwareTTS) . 2022
Comparison of Blood Pressure Variability Between 24H Ambulatory Monitoring and Office Blood Pressure in Diabetics and Non-diabetic Patients a Cross-Sectional Study.
Investigador Principal: Jorge Manuel da Silva Junqueira Polónia
Estudo Clínico Académico . 2021
Hipertensão da bata branca: prognóstico cardiovascular quando definida pela normalidade da pressão arterial noturna.
Investigador Principal: Jorge Manuel da Silva Junqueira Polónia
Estudo Clínico Académico . 2022
Citar a publicação
da RF,Silva A,Morato M,Ribeiro I,Polónia JJ. Embracing Uncertainties Over the Evidence of New Oral Antivirals for COVID-19: Challenges in Pharmacoepidemiologic Research. J. Clin. Pharmacol. 2023. 63(5):p. 521-525. IF:2,900. (3).
